当前位置: 首页 > 医学版 > 期刊论文 > 医药卫生总论 > 医药产业资讯 > 2008年 > 第28期
编号:12751199
冬凌草甲素抗肿瘤机制实验研究概况(1)
http://www.100md.com 2008年10月5日 中国医药导报
     [摘要] 冬凌草甲素(Oridonin)具有明显的抗肿瘤作用,既可以抑制细胞增殖,抑制核转录因子-KB(NF-KB),丝裂原活化蛋白激酶(MAPK),表皮生长因子受体等相关信号通路防止肿瘤发生,诱导细胞凋亡,也可以抑制毒性药物损伤自身细胞DNA,增强吞噬细胞吞噬作用等,有望成为一种天然抗癌新药。

    [关键词] 肿瘤;细胞凋亡;冬凌草甲素

    [中图分类号] R73-3 [文献标识码]A [文章编号]1673-7210(2008)10(a)-014-03

    Molecule mechanisms of Oridonin on tumors chemoprevention and therapy

    WANG Zhen-ni1,WO Xing-de1,ZHOU Yong-lie2

    (1.College of Life Science ,Zhejiang University of Traditional Chinese Medical,Hangzhou 310053,China;2.Central Laboratory,Zhejiang Provincial People's Hospital,Hangzhou 310014,China)

    [Abstract] Oridonin posses remarkable anticancer potential.It not only prevents tumorigenesis and induces apoptosis through inhibiting related signaling pathways such as nuclear factor-kB(NF-kB),mitogen-activated protein kinase (MAPK),epidermal growth factor receptor(EGFR) and so on,but also prevents the noxious drug damaging DNA and enhaces phagocytosis of apoptotic.It is likely to be used as an chemopreventive and therapeutic drug in the future.

    [Key words] Tumor;Apoptosis;Oridionin

    冬凌草甲素(Oridonin)是从唇形科香茶菜属植物中分离出的一种四环二萜类化合物 ......
1 2 3 4下一页

您现在查看是摘要页,全文长 4879 字符